Related Articles
Decoding the heterogeneous landscape in the development prostate cancer (Review)
Xenograft and organoid models in developing precision medicine for gastric cancer (Review)
Organoids and epithelial ovarian cancer ‑ a future tool for personalized treatment decisions? (Review)
Maximum allele frequency observed in plasma: A potential indicator of liquid biopsy sensitivity
Precision medicine for respiratory diseases: A current viewpoint